Press release
Investigation announced for Long-Term Investors in Instadose Pharma Corp. (OTC: INSD)
An investigation on behalf of current long term investors in Instadose Pharma Corp. (OTC: INSD) shares.
Investors who are current long term investors in Instadose Pharma Corp. (OTC: INSD) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in OTC: INSD stocks follows a lawsuit filed against Instadose Pharma Corp. over alleged securities laws violations. The investigation on behalf of current long term investors in OTC: INSD stocks, concerns whether certain Instadose Pharma directors are liable in connection with the allegations made in that lawsuit.
According to that complaint filed in the U.S. District Court for the Eastern District of Virgina the plaintiff alleges that, the Defendants made false and/or misleading statements and/or failed to disclose that Instadose had performed inadequate due diligence into the Business Combination and/or ignored significant red flags associated with Instadose Canada, that Instadose's internal controls and policies were inadequate to detect and/or prevent impermissible trading activity by control persons of the Company, that the foregoing subjected Instadose to a heightened risk of regulatory scrutiny and enforcement action, and that as a result, the Company's public statements were materially false and misleading at all relevant times.
Those who purchased shares of Instadose Pharma Corp. (OTC: INSD) have certain options and should contact the Shareholders Foundation.
Contact:
Christopher Clausen
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Long-Term Investors in Instadose Pharma Corp. (OTC: INSD) here
News-ID: 2602661 • Views: …
More Releases from Shareholders Foundation
Lawsuit Alert: Investors who lost money with James Hardie Industries plc (NYSE: …
An investor, who purchased shares of James Hardie Industries plc (NYSE: JHX), filed a lawsuit over alleged violations of Federal Securities Laws by James Hardie Industries plc in connection with certain allegedly false and misleading statements.
Investors who purchased shares of James Hardie Industries plc (NYSE: JHX) have certain options and for certain investors are short and strict deadlines running. Deadline: December 23, 2025. NYSE: JHX investors should contact the Shareholders…
Investigation announced for Long-Term Investors in SelectQuote, Inc. (NYSE: SLQT …
An investigation on behalf of current long-term investors in shares of SelectQuote, Inc. (NYSE: SLQT) concerning potential breaches of fiduciary duties by certain directors and officers of SelectQuote, Inc. was announced.
Investors who are current long term investors in SelectQuote, Inc. (NYSE: SLQT) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term…
Lawsuit filed for Investors who lost money with shares of MoonLake Immunotherape …
An investor, who purchased shares of MoonLake Immunotherapeutics (NASDAQ: MLTX), filed a lawsuit over alleged violations of Federal Securities Laws by MoonLake Immunotherapeutics in connection with certain allegedly false and misleading statements.
Investors who purchased a significant amount of shares of MoonLake Immunotherapeutics (NASDAQ: MLTX) between March 10, 2024 and September 29, 2025, have certain options and for certain investors are short and strict deadlines running. Deadline: December 15, 2025. NASDAQ:…
Dow Inc. (NYSE: DOW) Investor Alert: Deadline in Lawsuit on October 28, 2025
A deadline is coming up on October 28, 2025 in the lawsuit filed for certain investors of Dow Inc. (NYSE: DOW) over alleged securities laws violations by Dow Inc.
Investors who purchased shares of Dow Inc. (NYSE: DOW) have certain options and there are strict and short deadlines running. Deadline: October 28, 2025. Dow Inc. (NYSE: DOW) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -…
More Releases for Instadose
Radiation Dosimeter Patch Market to Reach USD 586 Million by 2031 Top 20 Company …
The radiation dosimeter patch market delivers skin-applied or wearable devices that measure accumulated ionizing radiation exposure for people and patients across healthcare, nuclear power, industrial, research and emergency-response settings. These patches range from single-use thermoluminescent/chemical dosimeter stickers to reusable electronic polymer and active semiconductor sensor patches that provide near-real-time readouts. End users include hospitals and radiotherapy centers monitoring patient and staff dose, nuclear and utilities personnel needing occupational monitoring, industrial…
Deadline on February 28th coming up in Lawsuit for Investors in shares of Instad …
A deadline is coming up on February 28, 2022 in the lawsuit filed for certain investors of Instadose Pharma Corp. (OTC: INSD) over alleged securities laws violations by Instadose Pharma Corp.
Investors who purchased shares of Instadose Pharma Corp. (OTC: INSD) have certain options and there are strict and short deadlines running. Deadline: February 28, 2022. OTC: INSD stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -…
Lawsuit filed for Investors in shares of Instadose Pharma Corp. (OTC: INSD) file …
An investor, who purchased shares of Instadose Pharma Corp. (OTC: INSD), filed a lawsuit alleged violations of Federal Securities Laws by Instadose Pharma Corp. f/k/a Mikrocoze, Inc.
Investors who purchased shares of Instadose Pharma Corp. (OTC: INSD) have certain options and for certain investors are short and strict deadlines running. Deadline: February 28, 2022. OTC: INSD investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
Chesapeake, VA…
Investigation announced for Investors in Instadose Pharma Corp. (OTC: INSD)
An investigation was announced over potential securities laws violations by Instadose Pharma Corp. and certain of its directors and officers in connection with certain financial statements.
Investors who purchased shares of Instadose Pharma Corp. (OTC: INSD), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Instadose…
Radiation Detection, Monitoring And Safety Market Growth, Trends, And Forecast 2 …
The increased use of radioactive materials in areas, such as power production, industrial processing, medical research, processing, and the security sector, coupled with the increased threat of terrorism, has intensified the need for equipment offering protection against radioactive radiations. In addition, the amplified stability of manufacturing industries is likely to augment the growth of the market during the forecast period. The usage of radiography testing in the manufacturing industry to…
Dosimeters Market Estimated Growth By Leading Players Thermo Fisher Scientific I …
Global Dosimeters Market, by Product Type (Active Dosimeters and Passive Dosimeters), by Modality (Portable Dosimeters (Wearable (Collar Level, Chest Level, Waist Level, Wrist Level, and Finger Level (i.e. Ring Dosimeters)), and Non-wearable), and Bench-top Dosimeters), by End User (Hospitals, Ambulatory Care Centers, Research Institutes, and Healthcare Companies), and by Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) was valued at US$ 847.0 Mn in 2017,…
